Publicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (5)

2022

  1. Dehydroisohispanolone as a Promising NLRP3 Inhibitor Agent: Bioevaluation and Molecular Docking

    Pharmaceuticals, Vol. 15, Núm. 7

2020

  1. Dehydrohispanolone Derivatives Attenuate the Inflammatory Response through the Modulation of Inflammasome Activation

    Journal of Natural Products, Vol. 83, Núm. 7, pp. 2155-2164

2019

  1. Metal complexes of natural product like-compounds with antitumor activity

    Anti-Cancer Agents in Medicinal Chemistry, Vol. 19, Núm. 1, pp. 48-65

  2. α-hispanolol induces apoptosis and suppresses migration and invasion of glioblastoma cells likely via downregulation of MMP-2/9 expression and p38MAPK attenuation

    Frontiers in Pharmacology, Vol. 10, Núm. JULY

2018

  1. Semisynthesis and inhibitory effects of solidagenone derivatives on TLR-mediated inflammatory responses

    Molecules, Vol. 23, Núm. 12